Trial · NCT04076943
Results by group11
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 11 of 11
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Maximum Change in Hb Within 16 Weeks From Baseline Without Red Blood Cell (RBC) Transfusion | Roxadustat | 2.47 | Standard Deviation 1.510 | g/dL | |
| Mean Change in Hb Level From Baseline to Week 16 (Without RBC Transfusion) | Roxadustat | 1.20 | Standard Deviation 1.012 | g/dL | |
| Change in Hb From Baseline at Weeks 9, 13, and 16 (Without RBC Transfusion) | Roxadustat | Change at Week 9 | 1.43 | Standard Deviation 1.421 | g/dL |
| Change in Hb From Baseline at Weeks 9, 13, and 16 (Without RBC Transfusion) | Roxadustat | Change at Week 13 | 2.15 | Standard Deviation 1.921 | g/dL |
| Change in Hb From Baseline at Weeks 9, 13, and 16 (Without RBC Transfusion) | Roxadustat | Change at Week 16 | 2.52 | Standard Deviation 1.700 | g/dL |
| Percentage of Participants Who Achieved a ≥1 g/dL Increase in Hb From Baseline Through Week 16 | Roxadustat | 82.0 | 95% Confidence Interval 72.5 to 89.4 | percentage of participants | |
| Time to Achieve a ≥1 g/dL Increase in Hb From Baseline Through Week 16 | Roxadustat | 41.0 | 95% Confidence Interval 29.0 to 46.0 | days | |
| Percentage of Participants Who Achieved a ≥1.5 g/dL Increase in Hb From Baseline Through Week 16 | Roxadustat | 73.0 | 95% Confidence Interval 62.6 to 81.9 | percentage of participants | |
| Percentage of Participants Who Achieved a Hematopoietic Response | Roxadustat | 75.3 | 95% Confidence Interval 65.0 to 83.8 | percentage of participants | |
| Percentage of Participants Who Achieved a ≥2 g/dL Increase in Hb From Baseline Through Week 16 | Roxadustat | 60.7 | 95% Confidence Interval 49.7 to 70.9 | percentage of participants | |
| Percentage of Participants Who Had an RBC Transfusion From Beginning of Week 5 (Day 29) to Week 16 | Roxadustat | 14.5 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04076943/results